RE:RE:llike the run up, but...even though no news precipitated the run-up. Do you think SVA.v (Sernova) ran from .30 to .64 on news? nope, it ran from .64 to 2.40 on news.
The smart and lucky $ gets in before the news.
Where there is smoke there is fire.
As well, why does there always have to be news to substantiate a stock's run?
How about just the fact that we've been undervalued and underfollowed for such a long time (for various reasons) that certain investors are now waking up to that fact based on the news that the company
has already released like:
- that our transporter technology xB3 has shown to get more into the brain than Denali's,
- or that a major pharma, Chiesi (in Italy), with $2B in revenues in 2019 paid us upfront monies ($3m USD) and huge milestone$ ($138m USD) to license our technology https://www.bioasis.us/bioasis-and-chiesi-group-announce-rare-diseases-strategic-alliance/
- or that the CNS and blood-brain barrier technology marketplace is hot as evidenced by our competitor, Denali, having a mkt cap of about $13B CDN and Bioasis' was about $30m CDN.